RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Outset Medical Stock

Outset Medical P/S 2024

Outset Medical P/S

1.67

Ticker

OM

ISIN

US6901451079

WKN

A2QB2U

As of Nov 1, 2024, Outset Medical's P/S ratio stood at 1.67, a -79.88% change from the 8.3 P/S ratio recorded in the previous year.

The Outset Medical P/S history

Outset Medical Aktienanalyse

What does Outset Medical do?

Outset Medical is an American company that has been offering leading products in the field of innovative dialysis worldwide since 2014. The company was founded by Leslie Trigg, the former CEO of ICU Medical. Together with experienced dialysis developer and Chief Medical Officer Dr. Hirschorn, Trigg succeeded in making Outset Medical one of the most innovative and leading brands in the dialysis market. The company is headquartered in California and is engaged in dialysis research. It specializes in the development of dialysis solutions and offers devices for home and clinic treatments. Outset Medical's main product, the Tablo system, is a portable dialysis machine for home use. Tablo is a compact and lightweight alternative to traditional dialysis, which is usually performed in clinics. Outset Medical's business model is to create a better experience for patients by developing the Tablo device for home dialysis. This revolutionary system is designed for easier and more convenient use, aiming to improve the quality of life for dialysis patients. The company believes that dialysis treatment is a burdensome and time-consuming process that affects the quality of life for many patients. With the Tablo system, which gives patients greater autonomy and independence, they can comfortably and safely perform their dialysis treatment at home. However, Outset Medical not only offers the Tablo system for home dialysis. The company has also developed a Tablo HD version for clinic treatment, which covers the immediate need for high-quality dialysis solutions. Outset Medical's Tablo HD system is a state-of-the-art device used by medical professionals to ensure the best dialysis treatment for their patients. The Tablo HD system is used in clinics, hospitals, and dialysis centers around the world to enable patients to have a higher quality of life and provide them with the best medical outcomes. Outset Medical's range also includes a range of accessories and service solutions for hospital and home dialysis. This area offers a wide range of products and services for improving dialysis treatment during hospital and home treatment. Although Outset Medical currently has the greatest impact on the dialysis market, the company considers its competition to be cooperative. The Outset Medical group welcomes competition as a sign of growing interest in innovative dialysis solutions. The company also has partnerships with leading dialysis companies such as Fresenius Medical Care, a partnership aimed at promoting the adoption of the Tablo system in Europe and other parts of the world. The history of Outset Medical is a story of innovation and commitment to improving the quality of life for dialysis patients. The company is dedicated to providing better dialysis treatment and improved quality of life for dialysis patients. Outset Medical's successes in the dialysis industry show that the company is on the right track and pursuing its mission with passion and creativity. Overall, Outset Medical is a company committed to improving the quality of life for dialysis patients worldwide. Outset Medical has established itself as one of the most innovative and leading brands in the dialysis market, offering not only the Tablo system for home dialysis but also the Tablo HD system for clinic treatment. With its wide range of products and partnerships with some of the leading dialysis companies, Outset Medical continues its mission of providing better dialysis treatment and a higher quality of life for dialysis patients. Outset Medical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Outset Medical's P/S Ratio

Outset Medical's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Outset Medical's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Outset Medical's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Outset Medical’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Outset Medical stock

What is the price-to-earnings ratio of Outset Medical?

The price-earnings ratio of Outset Medical is currently 1.67.

How has the price-earnings ratio of Outset Medical changed compared to last year?

The price-to-earnings ratio of Outset Medical has increased by -79.88% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Outset Medical high compared to other companies?

Yes, the price-to-earnings ratio of Outset Medical is high compared to other companies.

How does an increase in the price-earnings ratio of Outset Medical affect the company?

An increase in the price-earnings ratio of Outset Medical would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Outset Medical affect the company?

A decrease in the price-earnings ratio of Outset Medical would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Outset Medical?

Some factors that influence the price-earnings ratio of Outset Medical are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Outset Medical pay?

Over the past 12 months, Outset Medical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Outset Medical is expected to pay a dividend of 0 USD.

What is the dividend yield of Outset Medical?

The current dividend yield of Outset Medical is .

When does Outset Medical pay dividends?

Outset Medical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Outset Medical?

Outset Medical paid dividends every year for the past 0 years.

What is the dividend of Outset Medical?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Outset Medical located?

Outset Medical is assigned to the 'Health' sector.

Wann musste ich die Aktien von Outset Medical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Outset Medical from 11/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/1/2024.

When did Outset Medical pay the last dividend?

The last dividend was paid out on 11/1/2024.

What was the dividend of Outset Medical in the year 2023?

In the year 2023, Outset Medical distributed 0 USD as dividends.

In which currency does Outset Medical pay out the dividend?

The dividends of Outset Medical are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Outset Medical

Our stock analysis for Outset Medical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Outset Medical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.